marketcaparena
Search

    HALO

    HALOZYME THERAPEUTICS, INC.

    Company overview

    Market capitalization
    $12.81B
    Employees
    423
    Latest publication
    2026-09-29
    About HALOZYME THERAPEUTICS, INC.

    Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 that facilitates subcutaneous (SC) administration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; and XYOSTED, an injection for SC administration of testosterone replacement therapy. The company also provides Herceptin (trastuzumab) under the brand name Herceptin Hylecta; and Phesgo to treat breast cancer; Mabthera SC for chronic lymphocytic leukemia treatment; Tecentriq SC for IV infusion; Ocrevus SC for multiple sclerosis; HYQVIA to treat primary immunodeficiency disorders; DARZALEX to treat amyloidosis, and smoldering and multiple myeloma; epinephrine Injection to treat allergic reactions; nivolumab and relatlimab to treat metastatic or unresectable melanoma; teriparatide injections; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. It has collaborations and licensing agreements with F. Hoffmann-La Roche, Ltd. and Hoffmann-La Roche, Inc.; Takeda Pharmaceuticals International AG and Baxalta US Inc.; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol Myers Squibb Company; argenx BVBA; ViiV Healthcare; Chugai Pharmaceutical Co., Ltd.; Acumen Pharmaceuticals, Inc.; Merus N.V.; and Skye Bioscience, Inc. The company was founded in 1998 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue480,999,000USD376,708,000USD451,767,000USD354,264,000USD325,719,000USD264,861,000USD298,008,000USD290,084,000USD
    Cost Of Revenue79,171,000USD108,750,000USD102,146,000USD73,004,000USD64,120,999USD66,165,000USD42,055,000USD49,426,000USD
    Gross Profit401,828,000USD267,958,000USD349,621,000USD281,260,000USD261,598,000USD198,696,000USD255,953,000USD240,658,000USD
    Research Development27,664,000USD25,560,000USD31,897,000USD17,251,000USD17,543,000USD14,799,000USD20,441,000USD18,458,000USD
    Selling General Administrative56,998,000USD57,881,000USD77,028,000USD46,088,000USD41,614,000USD42,362,000USD42,249,000USD41,241,000USD
    Total Operating Expenses114,174,000USD83,441,000USD95,225,000USD63,339,000USD59,157,000USD57,161,000USD80,452,000USD77,461,000USD
    Operating Income287,654,000USD184,517,000USD254,396,000USD217,921,000USD202,441,000USD141,535,000USD175,501,000USD163,197,000USD
    Total Other Income Expense Net-2,752,000USD-4,190,000USD-355,245,000USD1,037,000USD2,497,000USD2,293,000USD2,713,000USD1,950,000USD
    Interest Expense5,588,000USD5,508,000USD4,911,000USD4,296,000USD4,394,000USD4,525,000USD4,540,000USD4,524,000USD
    Income Before Tax284,902,000USD180,327,000USD-100,849,000USD218,958,000USD204,938,000USD143,828,000USD178,214,000USD165,147,000USD
    Income Tax Expense54,989,000USD30,278,000USD40,742,000USD43,733,000USD39,778,000USD25,733,000USD41,202,000USD28,136,000USD
    Net Income229,913,000USD150,049,000USD-141,591,000USD175,225,000USD165,160,000USD118,095,000USD137,012,000USD137,011,000USD
    Net Interest Income—-5,508,000USD-4,911,000USD-4,296,000USD-4,394,000USD-4,525,000USD-4,540,000USD-4,524,000USD
    Tax Provision—30,278,000USD40,742,000USD43,733,000USD39,778,000USD25,733,000USD41,202,000USD28,136,000USD
    Net Income From Continuing Ops—150,049,000USD-141,591,000USD175,225,000USD165,160,000USD118,095,000USD137,012,000USD137,011,000USD
    Ebit—185,835,000USD-95,938,000USD223,254,000USD209,332,000USD148,353,000USD182,754,000USD169,671,000USD
    Ebitda—219,568,000USD-69,258,000USD243,716,000USD229,794,000USD168,802,000USD203,169,000USD190,033,000USD
    Depreciation And Amortization—33,733,000USD26,680,000USD20,462,000USD20,462,000USD20,449,000USD20,415,000USD20,362,000USD
    Reconciled Depreciation—33,733,000USD26,680,000USD20,420,000USD20,502,000USD20,449,000USD20,415,000USD20,360,000USD
    Unclassified Operating Expenses——-13,700,000USD———17,762,000USD17,762,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20172017-12-31 · USDFY 20092009-12-31 · USD
    Total Revenue1,396,611,000USD1,015,324,000USD829,253,000USD660,116,000USD443,310,000USD267,594,000USD316,613,000USD13,671,305USD
    Cost Of Revenue305,436,000USD159,417,000USD192,361,000USD139,304,000USD81,413,000USD43,367,000USD31,152,000USD311,891USD
    Gross Profit1,091,175,000USD855,907,000USD636,892,000USD520,812,000USD361,897,000USD224,227,000USD285,461,000USD13,359,414USD
    Research Development81,490,000USD79,048,000USD76,363,000USD66,607,000USD35,672,000USD34,236,000USD150,643,000USD56,614,266USD
    Selling General Administrative207,092,000USD154,335,000USD149,182,000USD143,526,000USD50,323,000USD45,736,000USD53,816,000USD15,203,408USD
    Unclassified Operating Expenses-13,700,000USD71,049,000USD73,773,000USD43,148,000USD————
    Total Operating Expenses274,882,000USD304,432,000USD299,318,000USD253,281,000USD85,995,000USD79,972,000USD204,459,000USD71,817,674USD
    Operating Income816,293,000USD551,475,000USD337,574,000USD267,531,000USD275,902,000USD144,255,000USD81,002,000USD-58,458,260USD
    Interest Expense18,126,000USD18,095,000USD18,762,000USD16,947,000USD7,526,000USD20,378,000USD21,984,000USD0USD
    Net Interest Income-18,126,000USD-18,095,000USD-18,762,000USD-16,947,000USD-7,526,000USD-20,378,000USD-21,984,000USD—
    Income Before Tax466,875,000USD557,132,000USD348,329,000USD248,918,000USD248,518,000USD129,302,000USD61,610,000USD-58,360,523USD
    Income Tax Expense149,986,000USD113,041,000USD66,735,000USD46,789,000USD-154,192,000USD217,000USD-1,361,000USD—
    Tax Provision149,986,000USD113,041,000USD66,735,000USD46,789,000USD-154,192,000USD217,000USD-1,361,000USD—
    Net Income316,889,000USD444,091,000USD281,594,000USD202,129,000USD402,710,000USD129,085,000USD62,971,000USD-58,360,523USD
    Net Income From Continuing Ops316,889,000USD444,091,000USD281,594,000USD202,129,000USD402,710,000USD129,085,000USD62,971,000USD—
    Ebit485,001,000USD575,227,000USD367,091,000USD265,865,000USD275,902,000USD144,255,000USD81,002,000USD-58,360,523USD
    Ebitda573,052,000USD656,539,000USD451,947,000USD315,506,000USD278,899,000USD147,539,000USD83,163,000USD-56,916,785USD
    Depreciation And Amortization88,051,000USD81,312,000USD84,856,000USD49,641,000USD2,997,000USD3,284,000USD2,161,000USD1,443,738USD
    Reconciled Depreciation88,051,000USD81,312,000USD84,856,000USD49,641,000USD2,997,000USD3,284,000USD2,161,000USD—
    Total Other Income Expense Net-349,418,000USD5,657,000USD10,755,000USD-18,613,000USD-27,384,000USD-14,953,000USD2,592,000USD97,737USD
    Non Operating Income Net Other———-1,666,000USD-19,858,000USD5,425,000USD2,592,000USD—
    Net Income Applicable To Common Shares———202,129,000USD402,710,000USD129,085,000USD62,971,000USD—
    Interest Income——————19,392,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets2,577,408,000USD2,672,719,000USD2,525,323,000USD2,221,232,000USD2,053,899,000USD2,196,532,000USD2,063,477,000USD2,118,030,000USD
    Cash And Equivalents163,138,000USD———————
    Total Current Assets933,024,000USD1,003,036,000USD825,207,000USD1,328,749,000USD1,122,673,000USD1,262,028,000USD1,085,340,000USD1,126,976,000USD
    Other Current Assets109,059,000USD70,958,000USD64,639,000USD94,955,000USD76,652,000USD44,617,000USD38,951,000USD43,515,000USD
    Total Liabilities2,433,865,000USD———————
    Total Current Liabilities344,439,000USD363,210,000USD177,092,000USD837,228,000USD134,282,000USD150,379,000USD139,100,000USD108,815,000USD
    Other Current Liabilities111,861,000USD———————
    Other Non Current Liabilities102,681,000USD———————
    Total Stockholder Equity143,543,000USD219,636,000USD48,814,000USD503,915,000USD332,748,000USD482,270,000USD363,821,000USD452,703,000USD
    Total Equity Including Noncontrolling Interest143,543,000USD———————
    Short Long Term Debt208,970,000USD208,743,000USD—710,685,000USD————
    Long Term Debt1,937,684,000USD1,935,896,000USD2,142,630,000USD800,072,000USD1,509,100,000USD1,507,447,000USD1,505,798,000USD1,504,154,000USD
    Net Receivables453,327,000USD457,989,000USD441,273,000USD346,035,000USD316,339,000USD304,621,000USD308,455,000USD285,743,000USD
    Inventory137,135,000USD155,467,000USD176,475,000USD185,796,000USD181,505,000USD164,868,000USD141,860,000USD131,412,000USD
    Property Plant Equipment Net84,271,000USD82,230,000USD82,137,000USD71,420,000USD71,520,000USD72,816,000USD75,035,000USD74,490,000USD
    Goodwill581,732,000USD———————
    Intangible Assets922,443,000USD951,955,000USD981,467,000USD348,544,000USD366,306,000USD384,068,000USD401,830,000USD419,592,000USD
    Accounts Payable23,608,000USD14,098,000USD20,899,000USD15,360,000USD18,691,000USD20,074,000USD10,249,000USD12,398,000USD
    Common Stock114,000USD118,000USD118,000USD118,000USD118,000USD123,000USD123,000USD127,000USD
    Retained Earnings151,259,000USD204,835,000USD54,786,000USD502,146,000USD361,033,000USD477,964,000USD359,869,000USD397,629,000USD
    Accumulated Other Comprehensive Income-7,830,000USD-12,703,000USD-18,092,000USD-22,258,000USD-28,403,000USD-3,413,000USD3,829,000USD-6,939,000USD
    Total Liab—2,453,083,000USD2,476,509,000USD1,717,317,000USD1,721,151,000USD1,714,262,000USD1,699,656,000USD1,665,327,000USD
    Other Current Liab—140,369,000USD156,193,000USD111,183,000USD115,591,000USD130,305,000USD128,851,000USD96,417,000USD
    Capital Stock—118,000USD118,000USD118,000USD118,000USD123,000USD123,000USD127,000USD
    Good Will—582,323,000USD580,360,000USD416,821,000USD416,821,000USD416,821,000USD416,821,000USD416,821,000USD
    Cash—309,749,000USD133,820,000USD419,665,000USD61,861,000USD176,328,000USD115,850,000USD154,318,000USD
    Cash And Short Term Investments—318,622,000USD142,820,000USD701,963,000USD548,177,000USD747,922,000USD596,074,000USD666,306,000USD
    Net Debt—1,834,890,000USD2,008,810,000USD1,091,092,000USD1,447,239,000USD1,331,119,000USD1,389,948,000USD1,349,836,000USD
    Short Term Debt—208,743,000USD—710,685,000USD————
    Short Long Term Debt Total—2,144,639,000USD2,142,630,000USD1,510,757,000USD1,509,100,000USD1,507,447,000USD1,505,798,000USD1,504,154,000USD
    Short Term Investments—8,873,000USD9,000,000USD282,298,000USD486,316,000USD571,594,000USD480,224,000USD511,988,000USD
    Property Plant Equipment Gross—117,445,000USD115,296,000USD102,479,000USD100,728,000USD100,045,000USD100,464,000USD98,302,000USD
    Common Stock Shares Outstanding—122,875,000shares117,672,000shares122,331,000shares124,158,000shares126,644,000shares129,424,000shares130,134,000shares
    Non Current Assets Total—1,669,683,000USD1,700,116,000USD892,483,000USD931,226,000USD934,504,000USD978,137,000USD991,054,000USD
    Non Current Liabilities Total—2,089,873,000USD2,299,417,000USD880,089,000USD1,586,869,000USD1,563,883,000USD1,560,556,000USD1,556,512,000USD
    Non Current Liabilities Other—106,448,000USD113,863,000USD71,799,000USD77,769,000USD56,436,000USD54,758,000USD40,406,000USD
    Non Currrent Assets Other—53,175,000USD56,152,000USD55,698,000USD56,371,000USD55,609,000USD80,596,000USD80,151,000USD
    Net Working Capital—639,826,000USD648,115,000USD491,521,000USD988,391,000USD1,111,649,000USD946,240,000USD1,018,161,000USD
    Unclassified Current Liabilities—-208,743,000USD—-710,685,000USD————
    Unclassified Non Current Liabilities—47,529,000USD42,924,000USD—————
    Unclassified Equity—27,268,000USD11,884,000USD23,791,000USD—7,473,000USD—61,759,000USD
    Unclassified Non Current Assets————20,208,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets2,525,323,000USD2,063,477,000USD1,733,270,000USD1,841,511,000USD1,104,429,000USD579,924,000USD565,874,000USD440,248,000USD
    Intangible Assets981,467,000USD401,830,000USD472,879,000USD546,652,000USD————
    Other Current Assets64,639,000USD38,951,000USD48,613,000USD45,024,000USD40,482,000USD28,274,000USD33,373,000USD20,693,000USD
    Total Liab2,476,509,000USD1,699,656,000USD1,649,462,000USD1,671,713,000USD907,476,000USD428,877,000USD474,109,000USD191,361,000USD
    Total Stockholder Equity48,814,000USD363,821,000USD83,808,000USD169,798,000USD196,953,000USD151,047,000USD91,765,000USD248,887,000USD
    Other Current Liab156,193,000USD128,851,000USD99,715,000USD96,516,000USD24,441,000USD20,483,000USD55,649,000USD49,529,000USD
    Common Stock118,000USD123,000USD127,000USD135,000USD138,000USD135,000USD137,000USD145,000USD
    Capital Stock118,000USD123,000USD127,000USD135,000USD138,000USD135,000USD137,000USD145,000USD
    Retained Earnings54,786,000USD359,869,000USD90,550,000USD143,217,000USD-58,912,000USD-474,593,000USD-603,678,000USD-531,438,000USD
    Good Will580,360,000USD416,821,000USD416,821,000USD409,049,000USD0USD———
    Cash133,820,000USD115,850,000USD118,370,000USD234,195,000USD118,719,000USD147,703,000USD120,179,000USD57,936,000USD
    Cash And Short Term Investments142,820,000USD596,074,000USD336,000,000USD362,794,000USD740,922,000USD368,013,000USD421,262,000USD354,526,000USD
    Total Current Assets825,207,000USD1,085,340,000USD746,424,000USD739,013,000USD926,287,000USD554,764,000USD543,436,000USD427,849,000USD
    Total Current Liabilities177,092,000USD139,100,000USD112,494,000USD130,789,000USD117,147,000USD421,385,000USD85,637,000USD149,361,000USD
    Net Debt2,008,810,000USD1,389,948,000USD1,380,878,000USD1,271,905,000USD757,955,000USD249,525,000USD282,408,000USD68,444,000USD
    Short Long Term Debt Total2,142,630,000USD1,505,798,000USD1,499,248,000USD1,506,100,000USD876,674,000USD397,228,000USD402,587,000USD126,380,000USD
    Long Term Debt2,142,630,000USD1,505,798,000USD1,499,248,000USD1,492,766,000USD787,255,000USD—383,045,000USD34,874,000USD
    Short Term Investments9,000,000USD480,224,000USD217,630,000USD128,599,000USD622,203,000USD220,310,000USD301,083,000USD296,590,000USD
    Net Receivables441,273,000USD308,455,000USD234,210,000USD231,072,000USD90,975,000USD97,730,000USD59,442,000USD30,005,000USD
    Inventory176,475,000USD141,860,000USD127,601,000USD100,123,000USD53,908,000USD60,747,000USD29,359,000USD22,625,000USD
    Accounts Payable20,899,000USD10,249,000USD11,816,000USD17,693,000USD1,541,000USD1,928,000USD6,434,000USD4,079,000USD
    Property Plant Equipment Net82,137,000USD75,035,000USD74,944,000USD75,570,000USD8,794,000USD10,593,000USD10,855,000USD7,465,000USD
    Property Plant Equipment Gross115,296,000USD100,464,000USD94,605,000USD90,326,000USD21,894,000USD10,593,000USD10,855,000USD7,465,000USD
    Accumulated Other Comprehensive Income-18,092,000USD3,829,000USD-9,278,000USD-922,000USD-620,000USD22,000USD240,000USD-277,000USD
    Common Stock Shares Outstanding123,904,000shares129,424,000shares134,197,000shares140,608,000shares146,796,000shares141,463,000shares144,329,000shares143,599,000shares
    Non Current Assets Total1,700,116,000USD978,137,000USD986,846,000USD1,102,498,000USD178,142,000USD25,160,000USD22,438,000USD12,399,000USD
    Non Current Liabilities Total2,299,417,000USD1,560,556,000USD1,536,968,000USD1,540,924,000USD790,329,000USD7,492,000USD388,472,000USD42,000,000USD
    Non Current Liabilities Other113,863,000USD54,758,000USD37,720,000USD45,905,000USD544,000USD3,466,000USD4,180,000USD2,118,000USD
    Non Currrent Assets Other56,152,000USD80,596,000USD17,816,000USD26,801,000USD13,414,000USD14,567,000USD11,583,000USD4,934,000USD
    Net Working Capital648,115,000USD946,240,000USD633,930,000USD608,224,000USD809,140,000USD133,379,000USD457,799,000USD278,488,000USD
    Unclassified Non Current Liabilities42,924,000USD——-15,472,000USD—-3,466,000USD—-7,126,000USD
    Unclassified Equity11,884,000USD—2,282,000USD27,233,000USD256,209,000USD625,348,000USD694,929,000USD780,312,000USD
    Current Deferred Revenue——-32,197,000USD3,246,000USD1,746,000USD1,746,000USD4,012,000USD4,247,000USD
    Short Term Debt——6,580,000USD13,334,000USD89,419,000USD397,228,000USD19,542,000USD91,506,000USD
    Unclassified Current Liabilities——-5,617,000USD-13,334,000USD-89,419,000USD-397,228,000USD-19,542,000USD-91,506,000USD
    Other Liab———17,725,000USD3,074,000USD7,492,000USD2,313,000USD7,126,000USD
    Other Assets———71,227,000USD169,348,000USD14,567,000USD11,583,000USD4,934,000USD
    Short Long Term Debt———13,334,000USD89,419,000USD397,228,000USD19,542,000USD91,506,000USD
    Net Tangible Assets———-783,650,000USD196,953,000USD155,073,000USD90,518,000USD248,887,000USD
    Unclassified Non Current Assets———-26,801,000USD-13,414,000USD-14,567,000USD-11,583,000USD-4,934,000USD
    Deferred Long Term Liab——————2,494,000USD5,008,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation8,676,000USD
    Stock Based Compensation34,335,000USD
    Change To Account Receivables-17,385,000USD
    Change To Inventory45,711,000USD
    Change To Liabilities-47,833,000USD
    Change In Working Capital-69,763,000USD
    Operating Cash Flow420,969,000USD
    Capital Expenditures-7,914,000USD
    Net Investments-58,336,000USD
    Unclassified Investing Cash Flow710,000USD
    Investing Cash Flow-65,540,000USD
    Net Common Stock Issuance-332,729,000USD
    Unclassified Financing Cash Flow4,865,000USD
    Financing Cash Flow-327,864,000USD
    Change In Cash27,565,000USD
    End Cash Flow163,986,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income150,049,000USD-141,591,000USD175,225,000USD165,160,000USD118,095,000USD137,012,000USD137,011,000USD93,245,000USD
    Depreciation33,733,000USD26,680,000USD22,278,000USD22,354,000USD20,449,000USD22,259,000USD20,360,000USD22,166,000USD
    Stock Based Compensation16,637,000USD16,571,000USD12,160,000USD12,161,000USD10,673,000USD11,462,000USD12,578,000USD9,471,000USD
    Other Non Cash Items2,429,000USD343,566,000USD20,050,000USD-37,638,000USD390,000USD32,551,000USD-926,000USD14,478,000USD
    Change To Account Receivables-19,547,000USD-90,483,000USD-29,696,000USD-11,718,000USD3,834,000USD-22,712,000USD-71,220,000USD-18,621,000USD
    Change To Inventory27,379,000USD18,781,000USD-1,101,000USD-14,540,000USD-586,000USD-7,726,000USD1,980,000USD-21,402,000USD
    Change In Working Capital-26,198,000USD-9,429,000USD-51,116,000USD-62,326,000USD7,472,000USD-24,817,000USD-53,939,000USD-83,566,000USD
    Total Cash From Operating Activities180,078,000USD219,029,000USD178,597,000USD99,711,000USD154,221,000USD178,467,000USD115,376,000USD55,794,000USD
    Capital Expenditures-3,741,000USD-1,427,000USD-3,030,000USD-1,563,000USD-950,000USD-3,052,000USD-1,517,000USD-2,582,000USD
    Free Cash Flow176,337,000USD217,602,000USD175,567,000USD98,148,000USD153,271,000USD175,415,000USD113,859,000USD53,211,999USD
    Investments154,000USD273,375,000USD201,609,000USD84,788,000USD-90,422,000USD29,480,000USD-167,483,000USD-42,039,000USD
    Total Cashflows From Investing Activities-2,877,000USD-741,788,000USD201,609,000USD84,788,000USD-90,422,000USD29,480,000USD-167,483,000USD-42,039,000USD
    Total Cash From Financing Activities-1,613,000USD239,515,000USD-22,402,000USD-298,966,000USD-3,321,000USD-246,415,000USD18,561,000USD9,482,000USD
    Change In Cash175,929,000USD-285,845,000USD357,804,000USD-114,467,000USD60,478,000USD-38,468,000USD-33,546,000USD23,237,000USD
    Begin Period Cash Flow136,421,000USD419,665,000USD61,861,000USD176,328,000USD115,850,000USD154,318,000USD187,864,000USD164,627,000USD
    End Period Cash Flow312,009,000USD133,820,000USD419,665,000USD61,861,000USD176,328,000USD115,850,000USD154,318,000USD187,864,000USD
    Other Cashflows From Investing Activities710,000USD—204,639,000USD86,351,000USD—32,532,000USD—-39,457,000USD
    Other Cashflows From Financing Activities-1,613,000USD—16,481,000USD1,202,000USD-3,321,000USD3,585,000USD-167,483,000USD489,000USD
    Unclassified Operating Cash Flow3,428,000USD-16,768,000USD——-2,858,000USD———
    Sale Purchase Of Stock—0USD-38,883,000USD-300,168,000USD—-250,000,000USD489,000USD0USD
    Unclassified Investing Cash Flow—-1,013,736,000USD-201,609,000USD-84,788,000USD—-29,480,000USD—42,039,000USD
    Unclassified Financing Cash Flow—239,515,000USD————185,555,000USD8,993,000USD
    Net Borrowings—————0USD0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income316,889,000USD444,091,000USD281,594,000USD202,129,000USD402,710,000USD129,085,000USD-72,240,000USD-80,330,000USD
    Depreciation88,051,000USD88,662,000USD84,856,000USD57,480,000USD2,997,000USD3,284,000USD4,068,000USD2,388,000USD
    Stock Based Compensation51,565,000USD43,385,000USD36,620,000USD24,397,000USD20,820,000USD17,204,000USD34,776,000USD35,696,000USD
    Other Non Cash Items346,675,000USD39,196,000USD-10,334,000USD66,590,000USD24,609,000USD13,603,000USD-1,978,000USD1,697,000USD
    Change To Account Receivables-128,063,000USD-74,245,000USD-3,339,000USD-83,941,000USD6,755,000USD-38,288,000USD-29,437,000USD11,613,000USD
    Change To Inventory2,554,000USD-67,381,000USD-26,884,000USD-17,481,000USD7,371,000USD-31,388,000USD-6,734,000USD-17,480,000USD
    Change In Working Capital-152,256,000USD-136,270,000USD-38,671,000USD-110,486,000USD3,738,000USD-108,366,000USD-50,539,000USD-5,866,000USD
    Total Cash From Operating Activities651,558,000USD479,064,000USD388,571,000USD240,110,000USD299,440,000USD55,454,000USD-85,423,000USD-49,500,000USD
    Capital Expenditures-6,970,000USD-10,696,000USD-15,294,000USD-4,810,000USD-1,457,000USD-2,504,000USD-4,040,000USD-4,663,000USD
    Free Cash Flow644,588,000USD468,368,000USD373,277,000USD235,300,000USD297,983,000USD52,950,000USD-89,463,000USD-54,163,000USD
    Investments474,893,000USD-262,723,000USD-96,909,000USD490,919,000USD-404,832,000USD79,782,000USD-1,509,000USD7,156,000USD
    Total Cashflows From Investing Activities-545,813,000USD-262,723,000USD-96,909,000USD-487,005,000USD-406,289,000USD78,354,000USD-5,549,000USD2,493,000USD
    Net Borrowings451,132,000USD0USD-13,483,000USD617,443,000USD415,811,000USD-19,560,000USD338,989,000USD-77,516,000USD
    Total Cash From Financing Activities-85,174,000USD-218,861,000USD-407,987,000USD362,371,000USD77,865,000USD-106,284,000USD153,215,000USD-63,797,000USD
    Sale Purchase Of Stock-342,372,000USD-250,000,000USD-402,383,000USD-200,002,000USD-350,058,000USD-150,117,000USD-199,998,000USD13,719,000USD
    Change In Cash20,571,000USD-2,520,000USD-116,325,000USD115,476,000USD-28,984,000USD27,524,000USD62,243,000USD-110,804,000USD
    Begin Period Cash Flow115,850,000USD118,370,000USD234,695,000USD119,219,000USD148,203,000USD120,679,000USD58,436,000USD169,240,000USD
    End Period Cash Flow136,421,000USD115,850,000USD118,370,000USD234,695,000USD119,219,000USD148,203,000USD120,679,000USD58,436,000USD
    Other Cashflows From Investing Activities-287,771,000USD-252,027,000USD—516,925,000USD-404,832,000USD1,076,000USD-1,509,000USD7,156,000USD
    Other Cashflows From Financing Activities-215,763,000USD31,139,000USD7,879,000USD-62,174,000USD796,987,000USD63,393,000USD461,295,000USD13,719,000USD
    Unclassified Investing Cash Flow-725,965,000USD262,723,000USD15,294,000USD-1,490,039,000USD404,832,000USD—1,509,000USD-7,156,000USD
    Unclassified Financing Cash Flow21,829,000USD—13,483,000USD7,104,000USD-772,339,000USD63,393,000USD-432,847,000USD-13,719,000USD
    Dividends Paid——-13,483,000USD—-12,536,000USD-63,393,000USD-14,224,000USD—
    Unclassified Operating Cash Flow——34,506,000USD—-155,434,000USD——-3,085,000USD
    Change To Liabilities———24,535,000USD1,167,000USD-36,576,000USD4,638,000USD8,696,000USD
    Cash And Cash Equivalents Changes———115,476,000USD-28,984,000USD27,524,000USD62,243,000USD-110,804,000USD
    Issuance Of Capital Stock——————0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductBulk RHu PH2059,618,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCollaborative Agreements — Device Licensing And Development2,468,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees5,706,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCollaborative Agreements — Upfront Fees35,500,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductDevice Partnered Products14,580,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProprietary Products Sales55,428,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty307,699,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSales Based Milestone0USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductBulk RHu PH2073,497,000USD0001159036-26-000068
    Q1 2026Quarterly · 2026-03-31ProductDevice Partnered Products15,054,000USD0001159036-26-000068
    Q1 2026Quarterly · 2026-03-31ProductOther5,603,000USD0001159036-26-000068
    Q1 2026Quarterly · 2026-03-31ProductProprietary Products Sales41,873,000USD0001159036-26-000068
    Q1 2026Quarterly · 2026-03-31ProductRoyalty240,681,000USD0001159036-26-000068
    Q1 2026Quarterly · 2026-03-31ProductSales Based Milestone0USD0001159036-26-000068
    Q1 2026Quarterly · 2026-03-31ProductUpfront Fees0USD0001159036-26-000068
    FY 2025Yearly · 2025-12-31GeographyBelgium217,516,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31GeographyCH276,414,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31GeographyForeign Other33,334,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31GeographyJapan46,372,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31GeographyUnited States822,975,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductBulk RHu PH20133,023,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductCollaborative Agreements — Device Licensing And Development16,856,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees47,000,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductCollaborative Agreements — Salesbasedmilestone70,000,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductCollaborative Agreements — Upfront Fees18,471,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductDevice Partnered Products48,813,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductProprietary Products Sales194,608,000USD0001159036-26-000024
    FY 2025Yearly · 2025-12-31ProductRoyalty867,840,000USD0001159036-26-000024
    Q3 2025Quarterly · 2025-09-30ProductBulkr Hu PH2032,491,000USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductCollaborative Agreements — Device Licensing And Development3,998,000USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductCollaborative Agreements — Sales Based Milestone20,000,000USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductDevice Partnered Products9,495,000USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductEvent Based Development And Regulatory Milestone And Other Fees0USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductProprietary Products Sales52,242,000USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductRoyalty236,038,000USD0001159036-25-000045
    Q3 2025Quarterly · 2025-09-30ProductUpfront Fees0USD0001159036-25-000045
    Q2 2025Quarterly · 2025-06-30ProductBulkr Hu PH2023,271,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductCollaborative Agreements — Device Licensing And Development4,070,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees24,500,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductCollaborative Agreements — Sales Based Milestone10,000,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductDevice Partnered Products11,787,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductProprietary Products Sales46,452,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductRoyalty205,639,000USD0001159036-25-000034
    Q2 2025Quarterly · 2025-06-30ProductUpfront Fees0USD0001159036-25-000034
    Q1 2025Quarterly · 2025-03-31ProductBulkr Hu PH2027,025,000USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductCollaborative Agreements — Device Licensing And Development3,408,000USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductCollaborative Agreements — Sales Based Milestone15,000,000USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductCollaborative Agreements — Upfrontfees220,000USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductDevice Partnered Products14,675,000USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductEvent Based Development And Regulatory Milestone And Other Fees0USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductProprietary Products Sales36,341,000USD0001159036-25-000026
    Q1 2025Quarterly · 2025-03-31ProductRoyalty168,192,000USD0001159036-25-000026
    FY 2024Yearly · 2024-12-31GeographyBelgium84,005,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31GeographyCH212,391,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31GeographyForeign Other9,528,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31GeographyJapan18,939,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31GeographyUnited States690,461,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductBulk RHu PH2086,334,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductCollaborative Agreements — Device Licensing And Development11,341,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees72,500,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductCollaborative Agreements — Salesbasedmilestone30,000,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductCollaborative Agreements — Upfront Fees27,000,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductDevice Partnered Products50,538,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductProprietary Products Sales166,620,000USD0001159036-26-000024
    FY 2024Yearly · 2024-12-31ProductRoyalty570,991,000USD0001159036-26-000024
    Q3 2024Quarterly · 2024-09-30ProductBulkr Hu PH2031,493,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductCollaborative Agreements — Device Licensing And Development3,364,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees18,000,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductCollaborative Agreements — Upfront Fees27,000,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductDevice Partnered Products15,241,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductProprietary Products Sales39,925,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductRoyalty155,061,000USD0001159036-25-000045
    Q3 2024Quarterly · 2024-09-30ProductSales Based Milestone0USD0001159036-25-000045
    Q2 2024Quarterly · 2024-06-30ProductBulkr Hu PH2024,634,000USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductCollaborative Agreements — Device Licensing And Development2,049,000USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees25,500,000USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductDevice Partnered Products10,113,000USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductProprietary Products Sales44,139,000USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductRoyalty124,918,000USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductSales Based Milestone0USD0001159036-25-000034
    Q2 2024Quarterly · 2024-06-30ProductUpfront Fees0USD0001159036-25-000034
    Q1 2024Quarterly · 2024-03-31ProductBulkr Hu PH2010,511,000USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductCollaborative Agreements — Device Licensing And Development2,703,000USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees14,000,000USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductDevice Partnered Products12,818,000USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductProprietary Products Sales35,254,000USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductRoyalty120,593,000USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductSales Based Milestone0USD0001159036-25-000026
    Q1 2024Quarterly · 2024-03-31ProductUpfrontfees0USD0001159036-25-000026
    FY 2023Yearly · 2023-12-31GeographyBelgium58,354,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31GeographyCH149,024,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31GeographyForeign Other19,583,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31GeographyJapan15,096,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31GeographyUnited States587,196,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31ProductBulk RHu PH20115,442,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31ProductCollaborative Agreements — Device Licensing And Development9,534,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31ProductCollaborative Agreements — Event Based Development And Regulatory Milestone And Other Fees69,000,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31ProductCollaborative Agreements — Upfront Fees2,000,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31ProductDevice Partnered Products54,578,000USD0001159036-26-000024
    FY 2023Yearly · 2023-12-31ProductProprietary Products Sales130,834,000USD0001159036-26-000024

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.